Issue Date: November 25, 2013 | Web Date: November 22, 2013
Pharma Services Firm Debuts
DSM is joining with the New York City-based private equity firm JLL Partners to create NewCo, a drug manufacturing business that will have an estimated $2 billion in annual sales. The new firm—the name is said to be only temporary—will combine DSM’s pharmaceutical services business with the Canadian formulation specialist Patheon, which is 56% owned by JLL.
DSM is contributing its active ingredients and intermediates manufacturing business for a 49% . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society